Keywords: schering, ag, claims, upper, hand, ms, drug

Schering AG claims upper hand in MS drug trial

Article | 10 October 2001

Print This

Biogen, which is already under the threat of competition to itsbest-selling multiple sclerosis drug Avonex (interferon beta-1a) from Serono ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in